176 related articles for article (PubMed ID: 19963382)
21. Synthesis and biological evaluation of 3-(4-fluorophenyl)-1H-pyrazole derivatives as androgen receptor antagonists.
Guo G; Liu J; Wang G; Zhang D; Lu J; Zhao G
Anticancer Drugs; 2016 Apr; 27(4):278-85. PubMed ID: 26633887
[TBL] [Abstract][Full Text] [Related]
22. Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.
Shi Q; Wada K; Ohkoshi E; Lin L; Huang R; Morris-Natschke SL; Goto M; Lee KH
Bioorg Med Chem; 2012 Jul; 20(13):4020-31. PubMed ID: 22672984
[TBL] [Abstract][Full Text] [Related]
23. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
24. RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasion.
Nguyen QD; Faivre S; Bruyneel E; Rivat C; Seto M; Endo T; Mareel M; Emami S; Gespach C
FASEB J; 2002 Apr; 16(6):565-76. PubMed ID: 11919159
[TBL] [Abstract][Full Text] [Related]
25. Repression of the estrogen receptor-alpha transcriptional activity by the Rho/megakaryoblastic leukemia 1 signaling pathway.
Huet G; Mérot Y; Percevault F; Tiffoche C; Arnal JF; Boujrad N; Pakdel F; Métivier R; Flouriot G
J Biol Chem; 2009 Dec; 284(49):33729-39. PubMed ID: 19826002
[TBL] [Abstract][Full Text] [Related]
26. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
Edlund S; Landström M; Heldin CH; Aspenström P
Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
[TBL] [Abstract][Full Text] [Related]
28. Role of the TMPRSS2-ERG gene fusion in prostate cancer.
Tomlins SA; Laxman B; Varambally S; Cao X; Yu J; Helgeson BE; Cao Q; Prensner JR; Rubin MA; Shah RB; Mehra R; Chinnaiyan AM
Neoplasia; 2008 Feb; 10(2):177-88. PubMed ID: 18283340
[TBL] [Abstract][Full Text] [Related]
29. Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.
Hampl V; Martin C; Aigner A; Hoebel S; Singer S; Frank N; Sarikas A; Ebert O; Prywes R; Gudermann T; Muehlich S
EMBO Mol Med; 2013 Sep; 5(9):1367-82. PubMed ID: 23853104
[TBL] [Abstract][Full Text] [Related]
30. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
31. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
32. TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms.
Scharenberg MA; Pippenger BE; Sack R; Zingg D; Ferralli J; Schenk S; Martin I; Chiquet-Ehrismann R
J Cell Sci; 2014 Mar; 127(Pt 5):1079-91. PubMed ID: 24424023
[TBL] [Abstract][Full Text] [Related]
33. Megakaryoblastic leukemia protein-1 (MKL1): Increasing evidence for an involvement in cancer progression and metastasis.
Scharenberg MA; Chiquet-Ehrismann R; Asparuhova MB
Int J Biochem Cell Biol; 2010 Dec; 42(12):1911-4. PubMed ID: 20816842
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
35. A switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibition.
Klein RM; Higgins PJ
Mol Cancer; 2011 Sep; 10():114. PubMed ID: 21917148
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
Yamamura S; Saini S; Majid S; Hirata H; Ueno K; Deng G; Dahiya R
PLoS One; 2012; 7(1):e29722. PubMed ID: 22235332
[TBL] [Abstract][Full Text] [Related]
37. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
[TBL] [Abstract][Full Text] [Related]
38. Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.
Nie D; Guo Y; Yang D; Tang Y; Chen Y; Wang MT; Zacharek A; Qiao Y; Che M; Honn KV
Cancer Res; 2008 Jan; 68(1):115-21. PubMed ID: 18172303
[TBL] [Abstract][Full Text] [Related]
39. YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion.
Rahim S; Beauchamp EM; Kong Y; Brown ML; Toretsky JA; Üren A
PLoS One; 2011 Apr; 6(4):e19343. PubMed ID: 21559405
[TBL] [Abstract][Full Text] [Related]
40. Nuclear translocation of the SRF co-activator MAL in cortical neurons: role of RhoA signalling.
Tabuchi A; Estevez M; Henderson JA; Marx R; Shiota J; Nakano H; Baraban JM
J Neurochem; 2005 Jul; 94(1):169-80. PubMed ID: 15953360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
